No abstract available
MeSH terms
-
Aged
-
Amyloidogenic Proteins / blood
-
Amyloidosis* / complications
-
Amyloidosis* / diagnosis
-
Amyloidosis* / pathology
-
Amyloidosis* / physiopathology
-
Amyloidosis* / therapy
-
Anti-Arrhythmia Agents / therapeutic use
-
Anticoagulants / therapeutic use
-
Arrhythmias, Cardiac / diagnosis
-
Arrhythmias, Cardiac / etiology
-
Arrhythmias, Cardiac / physiopathology
-
Blood Vessels / pathology
-
Diagnosis
-
Diagnosis, Differential
-
Disease Progression
-
Diuretics / therapeutic use
-
Electrocardiography
-
Fatal Outcome
-
Heart Failure / diagnosis
-
Heart Failure / etiology
-
Heart Failure / physiopathology
-
Heart Failure / therapy
-
Hepatic Encephalopathy / blood
-
Hepatic Encephalopathy / etiology
-
Hepatic Encephalopathy / physiopathology
-
Humans
-
Kidney Failure, Chronic / blood
-
Kidney Failure, Chronic / etiology
-
Kidney Failure, Chronic / physiopathology
-
Kidney Failure, Chronic / therapy
-
Kidney Failure, Chronic / urine
-
Male
-
Myocardial Ischemia / diagnosis
-
Myocardium / pathology
-
Platelet Aggregation Inhibitors / therapeutic use
Substances
-
Amyloidogenic Proteins
-
Anti-Arrhythmia Agents
-
Anticoagulants
-
Diuretics
-
Platelet Aggregation Inhibitors